[Use of Hemospray® in post-sclerotherapy bleeding]

Area of Science:

• Gastroenterology
• Endoscopic Hemostasis
• Medical Devices

Context:

• Hemospray® is a novel device for endoscopic hemostasis in non-variceal gastrointestinal bleeding.
• It functions by increasing clotting factor concentration and creating a mechanical barrier.
• Indications include difficult access, massive bleeding, and coagulopathy.

Purpose:

• To report the successful use of Hemospray® in a pediatric patient with massive gastrointestinal bleeding.
• To evaluate the safety and efficacy of Hemospray® in controlling bleeding post-sclerotherapy in a child with acute liver failure and portal hypertension.
• To support the consideration of Hemospray® for massive bleeding control in pediatric patients.

Summary:

• A 2-year-old female with acute liver failure and portal hypertension experienced massive gastrointestinal bleeding after sclerotherapy.
• Hemospray® was applied endoscopically to control the bleeding.
• The procedure was successful, achieving hemostasis without complications.

Impact:

• Hemospray® demonstrated safety and efficacy in managing massive gastrointestinal bleeding in a pediatric case.
• This case suggests Hemospray® as a viable alternative for bleeding control in challenging pediatric gastrointestinal scenarios.
• Further investigation into Hemospray® use in pediatric populations is warranted.